Welcome to our dedicated page for Kneat Com news (Ticker: KSIOF), a resource for investors and traders seeking the latest updates and insights on Kneat Com stock.
KNEAT COM INC (OTCQX: KSIOF), also known as Kneat, regularly issues news updates that highlight its role in digitizing and automating validation and quality processes for highly regulated industries. Company announcements frequently cover new Master Services Agreements with global organizations in life sciences, healthcare technology, specialty chemicals, equipment manufacturing and related sectors, reflecting how its Kneat Gx platform is adopted across large, multi-site operations.
Investors and industry professionals following KSIOF news will see recurring themes around enterprise-scale deployments of Kneat Gx for computer systems validation, equipment validation, commissioning, qualification and validation (CQV), electronic logbooks, equipment testing workflows and drawing management processes. Many releases describe customers with operations in dozens of countries and thousands of employees, underscoring the platform’s use in complex, global environments.
Kneat’s news flow also includes financial results updates, where the company reports on total revenue, SaaS revenue, gross margin, and Annual Recurring Revenue (ARR), along with non‑IFRS metrics such as EBITDA and Adjusted EBITDA. These releases often discuss trends in new customer additions, expansions with existing customers and the company’s focus on scaling its SaaS business model.
Additional announcements highlight product evolution and AI capabilities, such as new versions of Kneat Gx that enhance data management, traceability, and support for risk-based validation approaches. Kneat also reports on external recognition, including leadership positions in G2 Pharma and Biotech software grids based on user satisfaction and market presence, and on events like its VALIDATE conference and investor presentations.
For readers interested in how digital validation and quality process automation are being adopted across life sciences and other regulated sectors, the KSIOF news page provides an ongoing view of Kneat’s customer wins, platform enhancements and financial performance.
Kneat Solutions (OTCQX: KSIOF) published its State of Validation 2026, based on over 600 validation professionals worldwide. The study finds rising validation workloads (80% increased; 45% significant), widespread digital tool adoption but limited full digital maturity (13% fully digital), and growing, human‑reviewed AI use in GxP settings.
Key metrics: 74% of implemented systems met or exceeded ROI expectations; 78% expect AI to be standard in validation by 2030. Paper remains common in core records.
kneat.com (OTCQX: KSIOF) signed a Master Subscription Agreement with one of Europe’s largest CDMOs to digitize equipment validation across more than two dozen production sites. The program targets stronger data integrity, traceability, standardization and improved audit readiness as the CDMO scales validation capacity.
The deal supports the CDMO’s corporate initiative to accelerate validation digitization driven by increased workload and a need for greater operational efficiency and scalability.
Kneat (TSX: KSI; OTCQX: KSIOF) will release first-quarter 2026 financial results for the quarter ended March 31, 2026, after TSX market close on May 13, 2026. A webcast conference call with CEO Eddie Ryan and CFO Dave O’Reilly will follow on May 14, 2026 at 09:00 ET (14:00 GMT).
According to the company, the webcast registration and the Q1 2026 results will be available in the Financial Information section of the Kneat Investors page at kneat.com/investors.
Kneat (OTCQX: KSIOF) released its 2025 shareholder letter highlighting resilient growth amid industry headwinds. The company reported software revenue +33% in 2025, $74M+ Annual Recurring Revenue and a Net Revenue Retention of 115%.
Kneat cited record new customers, 100% retention among core strategic customers, AI features for GxP environments, a 98/100 G2 satisfaction score, and an NPS above 70. Management expects improving operating efficiency and a path to cash-flow breakeven in 2026.
Kneat (OTCQX: KSIOF) reported record fourth-quarter and full-year 2025 results, with total revenue of $17.0M Q4 (+24% YoY) and $63.3M for 2025 (+29% YoY). ARR reached $74.1M at year-end (+24% YoY). Gross margin improved to 76–78%, Adjusted EBITDA was $9.5M for 2025, and net loss narrowed to $2.3M.
The company highlighted record new customer wins, strategic partnerships (Capgemini), AI product enhancements, leadership changes, and a 2026 target of cash-flow breakeven while anticipating typical second-half seasonality.
Kneat (TSX: KSI / OTCQX: KSIOF) announced a signed Master Services Agreement with a U.S.-headquartered global pharmaceutical packaging and drug-delivery manufacturer on Feb 19, 2026. The customer operates >45 manufacturing sites, including >12 GMP-regulated facilities, and employs over 13,000 people worldwide.
Under the agreement the customer will initially deploy Kneat Gx for CQV at a lead site, with planned expansion to all GMP sites, citing Kneat’s data integrity and audit-ready capabilities as decisive.
Kneat (OTCQX: KSIOF, TSX: KSI) said it will release fourth-quarter and full-year 2025 financial results after TSX close on February 25, 2026. A webcasted conference call and Q&A with CEO Eddie Ryan and CFO Dave O’Reilly is scheduled for February 26, 2026 at 09:00 ET (14:00 GMT).
Financial results will be posted in the Financial Information section of Kneat’s investors page at https://kneat.com/investors/.
Kneat (OTCQX: KSIOF) on January 6, 2026 announced a Master Services Agreement with a Europe‑headquartered biopharma research and manufacturing technology provider that employs 13,000+ people and operates in more than 60 locations. The customer will begin deploying Kneat’s digital validation platform for equipment validation at several manufacturing sites worldwide.
Kneat said the vendor selection followed a comprehensive evaluation citing measurable ROI and prior life‑sciences deployments. Management expects the customer to expand use enterprise‑wide over time, and the agreement is presented as reinforcing Kneat’s market position and supporting continued revenue growth.
Kneat (OTCQX: KSIOF) signed a three-year Master Services Agreement with one of the world’s largest specialty chemicals makers on Dec 17, 2025, adding momentum to a record year for new customer additions.
The customer has a Europe HQ, a footprint in >100 countries, manufacturing in >24 countries, and >30,000 employees. Kneat will deploy Kneat Gx for Computer System Validation (CSV), Equipment Validation, and electronic logbooks. Kneat cites ease of use, no-code configurability, data integrity, and validation expertise as competitive strengths driving high win rates in 2025.
Kneat (OTCQX: KSIOF) reported Q3 2025 total revenue $16.1M, up 26% year over year, driven by SaaS revenue $15.2M (+33% YoY). Gross profit was $12.2M and gross margin held near prior levels at 76%. ARR reached $68.6M, up 37% YoY. Q3 EBITDA was $3.8M and Adjusted EBITDA was $2.5M; Q3 net loss was $0.5M. Year-to-date revenue rose 31% to $46.3M and YTD EBITDA improved to $13.5M. Management highlighted new three-year MSAs, G2 category rankings, and AI product advancements while hosting a webcast on Nov 13, 2025.